Sign up


Match Document Document Title
9062298 Antidotes for factor XA inhibitors and methods of using the same  
The present invention relates antidotes to anticoagulants targeting factor Xa. The antidotes are factor Xa protein derivatives that bind to the factor Xa inhibitors thereby substantially...
9062113 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof  
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant,...
9055763 Probiotics for use in relieving symptoms associated with gastronitestinal disorders  
The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and...
9055742 Herbicide granules with built-in adjuvant  
Provided herein are herbicide granules containing non-petroleum derived built-in adjuvant.
9052138 Bulk freeze drying using spray freezing and stirred drying  
A freeze dryer processes bulk powder products. The freeze dryer freezes the product by mixing an atomized spray of product with sterile liquid nitrogen. The resultant powder is freeze dried in a...
9040032 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof  
Pharmaceutical compositions and their methods of use are provided, where the pharmaceutical compositions comprise an opioid prodrug that provides enzymatically-controlled release of an opioid, and...
9040034 Vitamin functionalized gel-forming block copolymers for biomedical applications  
Gel-forming block copolymers were prepared comprising i) a central hydrophilic block consisting essentially of a divalent poly(ethylene oxide) chain and ii) two peripheral monocarbonate or...
9040579 Combination therapy using coenzyme Q10 and a caffeic acid-derived ester  
A pharmaceutical composition containing a mitochondrial electron transport chain enhancer (or an antioxidant) and a compound of formula (I) shown in the specification. This pharmaceutical...
9040057 Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases  
A method of providing protection against pneumococcal infection in a subject is disclosed. The method includes steps of administering to the subject a composition that includes combination of...
9040079 Pegylated compounds for age-related macular degeneration  
A special photosensitizer formulation and Photodynamic Therapy method for treating choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) is provided. CNV is a...
9040296 Production of viral vaccines in suspension on avian embryonic derived stem cell lines  
The present invention relates to the development and manufacturing of viral vaccines. In particular, the invention relates to the field of industrial production of viral vectors and vaccines, more...
9040096 Jasmonic acid compounds in cocoa products  
The invention provides methods for isolating and enhancing the levels of jasmonates from cacao plant sources. In a preferred embodiment, jasmonic acid and 12-hydroxy jasmonate sulfate are detected...
9040047 Combinations of anti ErbB antibodies for the treatment of cancer  
An article-of-manufacture is provided. The article-of-manufacture comprises a packaging material identified for treating cancer, packaging: (i) an anti-EGFR antibody comprising the CDR sequences...
9040070 Material for induction of hard tissue regeneration  
The present invention relates to a material for induction of hard tissue regeneration, comprising platelet-rich plasma and gelatin β-TCP sponge, which promotes angiogenesis, osteogenesis,...
9040099 Botanical composition and method for treating pain and discomfort of various conditions  
A botanical composition made from a plurality of plant materials selected from Gota Kola (Centella asiatica), Turmeric Root (Curcuma longa), White Willow (Salix alba), Rosehips (Rosa canina),...
9040024 Composition and aerosol spray dispenser for eliminating odors in air  
An air treating composition for eliminating airborne malodors and/or sanitizing air in combination with a spray valve and actuator and spray performance parameters providing maximum dispersion of...
9040100 Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extract  
A method of treating prostate cancer by administering a pharmaceutically-acceptable amount of a crude extract of the indigenous Jamaican plant Ball Moss (Tillandsia Recurvata) comprising one or...
9040048 Antibody molecules having specificity for human OX40  
The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
9040058 Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use  
The present invention relates to a fermentation medium for cultivating Corynebacterium diphtheriae. The present invention also relates to the use of the fermentation medium in processes for...
9040064 Low-odor dimethicone copolyol sulfosuccinate surfactant compositions  
Dimethicone copolyol sulfosuccinate surfactant compounds having low-odor characteriztics are disclosed. The low-odor dimethicone copolyol sulfosuccinate is substantially free from propionaldehyde...
9040086 Timed, sustained release systems for propranolol  
A unit dosage form, such as a capsule or the like for delivering drugs into the body in a circadian release fashion, is comprising of one or more populations of propranolol-containing particles...
9040068 Control of bed bugs  
A method of combating bed bugs and/or other insects in a locus containing or susceptible to presence of same, in which a DMSO-containing formulation is applied to the locus. Various pesticidal...
9040076 Switchable adhesives  
The present invention provides switchable adhesives comprising a mixture, in proportions by weight, of 20% to 98% of an adhesive, 2% to 80% of curable molecules and 0.05% to 10% of photoinitiator...
9040035 Treatment of pain using placental stem cells  
Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture...
9040111 Method of making a stent  
A method of making a stent, including preparing a solution containing a composition, the composition comprising a biodegradable polymer and a vascular intimal hyperplasia inhibitor of a kind,...
9040097 Compositions for improving skin appearance  
Compositions for reducing the appearance of wrinkles, reducing the effects of aging and/or improving the appearance of skin. The composition may include at least one fluorinated perfluorocarbon;...
9040668 Anti-serum albumin binding variants  
The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-11, as well as ligands and drug conjugates comprising such variants, compositions,...
9040277 Mannanase variants  
The present disclosure provides novel mannanase variants which have an amino acid sequence that varies from that of the parent/wild type Trichoderma reesei mannanase, and which have one or more...
9040084 Pharmaceutical formulation containing gelling agent  
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically...
9040051 Marker genes for regulatory T cells from human blood  
The present invention provides novel marker genes for the specific identification and characterization of human suppressive and/or regulatory T cells including natural, adaptive, and expanded...
9040017 Liver-receptor imaging injection, dispensing method and pharmaceutical composition thereof  
The present invention is related to a pharmaceutical composition for a liver-receptor imaging injection, the pharmaceutical composition including a bi-functional compound which has a ASGPR...
9040018 Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor  
Monoclonal antibodies (MoAbs or mAbs) specific for ALPHA-ACTININ-4 antigens, hybridoma lines that secrete these ALPHA-ACTININ-4 mAbs, and the use of such mAbs to detect ALPHA-ACTININ-4 antigens,...
9040104 Compositions comprising Docynia delavajy extract and/or Elaeagnus lancelotus extract  
Disclosed are compositions that include Docynia delavajy extract, Elaeagnus lanceolatus extract, or a combination of such extracts.
9040106 Pharmaceutical composition for preventing or treating diabetic erectile dysfunction comprising C3G or extract of mulberry containing C3G  
The present invention relates to the ameliorating effects of C3G (Cyanidin-3-O-β-d-glucopyranoside) on diabetic erectile dysfunction. In particular, the present invention relates to a...
9040055 Conjugation of streptococcal capsular saccharides  
Three conjugation methods for use with the capsular saccharide of Streptococcus agalactiae. In the first method, reductive animation of oxidized sialic acid residue side chains is used, but the...
9040052 Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment  
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
9040037 Culture medium for Lactobacillus acidophilus and Streptococcus faecalis, composition comprising the same and preparation method thereof  
The present invention provides a triple vital bacteria composition, including: powder of Bifidobacterium longum, powder of Lactobacillus acidophilus, and powder of Streptococcus faecalis. The...
9040046 Sodium pump antibody agonists and methods of treating heart disease using the same  
Antibodies that are agonists of sodium pump (Na+/K+ ATPase; NKA) activity are provided. In particular, antibodies that specifically bind epitopes on the beta-1 (β1) subunit of NKA are disclosed....
9040060 Hydrolytically degradable alkylene oxide based polymers  
The present invention provides a water soluble, non-peptidic polymer comprising two or more alkylene oxide-based oligomers linked together by hydrolytically degradable linkages such as carbonates....
9040039 Modalities for the treatment of degenerative diseases of the retina  
This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment...
9040038 Modalities for the treatment of degenerative diseases of the retina  
This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment...
9040094 Flaky particle and cosmetic  
The present invention has an object to provide a flaky particulate material giving skin an excellent smoothness, which is free from whitening problem upon use thereof owing to its high...
9040088 Nanoparticulate megestrol formulations  
The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
9040029 Leave-in hair conditioning composition  
Present invention relates to a non-aqueous leave-in conditioning composition for hair, especially for strongly damaged hair by chemical processes such as permanent shaping, oxidative coloration...
9040036 Compositions for probiotic recolonisation therapy  
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in...
9040101 Method to treat diabetes utilizing a gastrointestinal microbiome modulating composition  
Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure teaches compositions and methods for treating diabetes utilizing a gastrointestinal...
9040105 Nanocrystals and amorphous nanoparticles and method for production of the same by a low energy process  
A process for the production of nanocrystals or amorphous nanoparticles of actives (nanomaterials), especially from the peels of grapes. A dispersion of a micrometer-sized material in a solution...
9040085 Delayed release tablet with defined core geometry  
A tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85...
9040626 Nanofibers and morphology shifting micelles  
The invention discloses novel morphology shifting micelles and amphiphilic coated metal nanofibers. Methods of using and making the same are also disclosed.
9040023 Method of treating a mammalian teat and related compositions  
A method of treating or protecting a mammalian teat by applying a topical composition to the teat, wherein the topical conditioning composition comprises (a) citrate; (b) methylene blue; and (c)...